STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Moberg Pharma (STO:MOB) Moberg Pharma AB (OMX: MOB) today announced that the European Patent Office has issued patent no. 2,777,689 for an improved formulation of Moberg Pharma’s market-leading OTC product for the treatment of fungal nails, sold in the U.S. under the Kerasal Nail® brand. The patent expires in 2034.The new European patent comprises composition of matter claims directed to novel formulations for topical application to the nails. The co
| < Prev | Next > |
|---|
